146.10 +0.91 (0.63%)
After hours: 4:32PM EST
|Bid||145.10 x 800|
|Ask||146.10 x 1100|
|Day's Range||142.18 - 145.62|
|52 Week Range||110.21 - 155.33|
|Beta (3Y Monthly)||0.80|
|PE Ratio (TTM)||26.11|
|Earnings Date||Feb 13, 2019 - Feb 18, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||152.25|
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! ICON Public Limited Company's (NASDAQ:ICLR) latest earnings update in DecemberRead More...
PORTLAND, Ore. and CAMBRIDGE, Mass., Feb. 21, 2019 -- MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation.
Icon PLC (ICLR) delivered earnings and revenue surprises of 1.25% and 0.47%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Dublin-based company said it had net income of $1.62. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research ...
Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICON PLC NASDAQ/NGS:ICLRView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for ICLR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ICLR. Money flowETF/Index ownership | PositiveETF activity is positive but appears to be weakening. Over the last month, growth of ETFs holding ICLR is favorable, with net inflows of $577 million. This is among the highest periods of net inflows seen over the last one-year, but the rate of additional flows appears to be decreasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
ICON plc, (ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of a new drug safety reporting solution based on an innovative cloud-based system, featuring automated and configurable business rules. The solution ensures compliance in an increasingly complex regulatory environment and enables the sponsor to gain visibility into the safety profile of an investigational product throughout its lifecycle. Using regulatory intelligence from 80 countries, the system is configured with date-stamped decision rules.
In September 2018, ICON Public Limited Company (NASDAQ:ICLR) released its earnings update. Generally, analyst forecasts appear to be conservative, with earnings growth rate expected to be 17% next year, which Read More...
ICON plc (ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced its financial guidance for the year ended December 31, 2019. For the full year 2019 revenue is expected to be in the range of $2,735 - $2,835 million, representing growth of 5.2 – 9.0% and earnings per share is expected to be in the range of $6.69 - $6.89, representing growth of 10.6 – 13.9%.
As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean, I look at stocks holistically, from their financial health to Read More...
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war with China, many smart money investors are keeping their optimism regarding the current bull run, while still hedging many of their long positions. However, as we know, […]
Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as ICON Public Limited Company (NASDAQ:ICLR), with a market cap of US$7.9b, often Read More...
Deciding if you should use a relative valuation model over an intrinsic valuation model can be a difficult choice for many investors. For instance, while my relative valuation model tells Read More...